Longcharm Bio

Longcharm Biotech is a clinical-stage biopharmaceutical company based in Shanghai, China, specializing in the development of complex long-acting injectable formulations. The company leverages its proprietary microsphere and nanocrystal technology platforms to create improved versions of existing therapies for central nervous system disorders, oncology, and metabolic diseases. Its lead programs include long-acting formulations of risperidone and paliperidone for schizophrenia, as well as exenatide for diabetes. Longcharm aims to improve patient compliance and therapeutic outcomes through sustained-release drug delivery systems. The company maintains high-standard GMP manufacturing capabilities specifically designed for microsphere production.